I am a matrix leader who strives to transform global health through improving patient access to breakthrough scientific innovations, thriving in complex and uncertain situations. How can we do the business of health better together? Over my 8+ year career in industry, I have launched 2alliance products into competitive US and global markets: BAVENCIO® + INLYTA® immunotherapy for advanced renal cell carcinoma, and COMIRNATY® COVID-19 mRNA vaccine, as well as matured Global and US commercial and market access strategy year-over-year for a late-stage potentially first-in-class asset (C. difficile vaccine).

In my current role as Global Market Access & Pricing Strategy Director at Pfizer Inc., I develop the payer strategy, including value proposition and pricing strategy, to enable patient access to our vaccines from launch, working closely with country affiliates. Since April 2020, I have supported the global launch of our COVID-19 Vaccine (COMIRNATY), driving towards accelerated and equitable access globally through advanced purchase agreements with national and supra-national organizations. For the past 8 months, I have been focused on the US, partnering cross-functionally to prepare for future public health needs and ensure continued access as theCOVID-19 pandemic and landscape evolves. Additionally, I am responsible for developing the Global Market Access & Pricing Strategy, leading the Market Access Working Group and co-leading the matrixed Global Commercial Launch Team for our late-stage pipeline C. difficile vaccine.

At Pfizer, I have been recognized by peers and management for my leadership having received 5monetary awards from peers, 1 “Boldly Done” award from the Chief Business Officer and an award from the President of Vaccines Business Unit for my role supporting COVID-19 Vaccine roll-out.
Previously, I have served in roles of increasing responsibility in Health Economics & Outcomes Research (e.g., cost-effectiveness modeling, epidemiology) across vaccines and immune-oncology at Pfizer, and diagnostics and medical devices at Becton Dickinson, & Co.

I hold a Master of Business Administration from UNC Chapel Hill Kenan-Flagler Business School, a master’s degree (MPH) in Epidemiology from Columbia University, and a bachelor’s (BS) in Public Health from Tulane University graduating magna cum laude.